Professor Of Pathology Research Articles

Alice Hamilton: A Legacy of Advancing Occupational Health and Safety Standards.

Alice Hamilton was a physician, research scientist, and author from America. She was a prominent figure in the occupational health industry, established the groundwork for safety measures, and was a trailblazer in industrial toxicology. Hamilton received medical training at the University of Michigan Medical School. While living at Hull House in Chicago from 1887 to 1919, she interacted with a wide range of working-class families and learned about the risks they encountered in their daily lives. In 1897, she was appointed as a pathology professor at the Woman's Medical School of Northwestern University. In 1919, she made history as the initial female faculty member of Harvard University. Furthermore, Hamilton researched mercury, carbon monoxide, rubber, and the munitions industries, in addition to her authoritative work on hazardous lead trades, such as smelting, refining, painting, and manufacturing. She wrote more than 80 scientific reports in 40 years. The U.S. Occupational Safety and Health Act was passed three months after she died in 1970.

Sensory science

Professor Adrian Liston, FMedSci, FRSB, is Professor of Pathology at the University of Cambridge. His research team works on systems immunology and tissue immunology, with a particular focus on understanding and treating neuroinflammation. Liston also writes extensively on career development and on the implementation of positive research culture practices. Sensory science was part of a broader effort by the laboratory to incorporate innovative approaches to expand the impact of science communication.

The Central Cord Syndrome in Patients with Cervical Spinal Cord Tumors: A 19th-Century Vignette from (Karl) Julius Vogel (1814-1880).

Between 1830 and 1850, (Karl) Julius Vogel was one of the most important German pathologists. He received his doctorate in medicine in 1838 from the University of Munich and habilitation in pathology in 1840. In 1846, he moved to the University of Giessen as a full professor of pathology. From 1855, he taught special pathology and therapy at the University of Halle and became director of the internal clinic. Vogel and Heinrich Adolph Karl Dittmar were the first clinicians to describe the symptoms and pathologic findings of the central cord syndrome in a cervical spine tumor.

Carl Weigert's pioneer definition of heart infarction as myocardial, coagulative necrosis due to obstruction of atherosclerotic coronary arteries in 1880, overshadowed by subsequent, secondary publications in the field.

In 1880, a German Jewish Professor of Pathology, Carl Weigert (1845-1904) first defined heart infarction as myocardial, coagulative necrosis ("Coagulationsnekrose") due to obliteration of atherosclerotic coronary arteries thanks, at least, partially to his great diligence in vascular staining methods. Histochemical techniques made his name eponymic as Weigert's Hematoxylin or Weigert's and Van Gieson's elastic stains are still used in routine practice to visualize, e.g., the framework of vessels. However, his discovery has been overshadowed by far more frequently cited in recent decades, subsequent but secondary, 214-page-long book dated on 1896 and titled "L'infarctus du myocarde et ses conséquences - ruptures, plaques fibreuses, anévrismes du coeur", in which René Marie repeated Carl Weigert's words that dead cardiomyocytes lost their cellular nuclei. Weigert introduced the term "die Infarcte des Herzmuskels", in 1880, in his paper titled "Über die pathologischen Gerinnungsvorgänge", in Virchows Archiv. According to Weigert, occlusions were caused by white thrombi ("weissen Thromben") on the ground of atheromatous changes of the coronary arteries. In following manner, he gave macroscopic description of heart infarction: "If a blood supply is very roughly (German: brüsk), completely cut off in individual parts of the heart muscle, yellowish dry masses are formed that resemble coagulated fibrin". "If examined microscopically, one usually does not find any fibrinous material exudate, but often a delusively normal tissue (sometimes you can even see cross striation of the muscle fibers): but all muscle fibers (...) are anucleate". Paradoxically, coronary thrombosis was also a cause of Carl Weigert's death.

Editorial introductions.

Current Opinion in Oncology was launched in 1989. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of psychiatry is divided into 15 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue. SECTION EDITORS Joel GuigayJoel GuigayJoël Guigay is Professor of Medicine, Past Director of Cancer Center Antoine-Lacassagne in Nice, France, and Past President of the Head & Neck-Unicancer group. Prior to this, he was Head Physician in the Department of Head & Neck and Thoracic Medical Oncology at Gustave Roussy in Villejuif, France. Professor Guigay received his Medical Degree from Lyon University of Medicine, France, in 1984 and subsequently undertook extensive postgraduate training in Pneumology, Cancerology, Oncogenesis, and Thoracic Endoscopy. In 2001, he was appointed Professor of Medicine at the Hôpital d’Instruction des Armées Val-de-Grâce in Paris, France. He currently serves as Head of partnerships and clinical development - Early assets for the Groupe Oncologie Radiothérapie Tête et Cou (GORTEC), and as deputy director of the Hospital University Federative OncoAge. In addition, he is an active member of many national and international societies, including the American Society of Clinical Oncology (ASCO), the European Society for Medical Oncology (ESMO) as a Faculty member for Head and Neck cancers and as a member of the OncologyPro WG, as Co-Chair of the scientific committee of the Head and Neck Cancer International Group (HNCIG). His main fields of interest are head and neck and lung oncology with a focus on rare tumors, salivary gland tumors, nasopharyngeal cancers and neuroendocrine tumors. His areas of research include clinical studies with new drugs and translational research with a focus on immunotherapy. Professor Guigay coordinates several clinical trials including phase I to large randomized trials in recurrent or metastatic HNSCC such as TPExtreme trial. He currently leads also a large research program for elderly head and neck cancer patients (ELAN study). Arif HussainArif HussainArif Hussain, MD, is Professor of Medicine with Tenure in the Department of Medicine, School of Medicine, at the University of Maryland in Baltimore, USA, where he is also Professor of Biochemistry in the Department of Biological Chemistry and Professor of Pathology in the Department of Pathology. He serves as Co-Leader of the Hormone Related Cancers Program at the University of Maryland Greenebaum Comprehensive Cancer Center. Dr Hussain's clinical interest is in genitourinary cancers, and he serves as Principal Investigator on several clinical trials that focus on therapies for high risk, recurrent and metastatic prostate cancer, as well as renal cell cancer. In addition, he has a research laboratory with a translational focus, studying drug resistance and adaptive intracellular signaling pathways in treatment-sensitive and treatment-resistant prostate cancer.

Regional Institute of Ophthalmology and Government Ophthalmic Hospital: The Heart of Heritage

Regional Institute of Ophthalmology and Government Ophthalmic Hospital: The Heart of Heritage

Editorial introductions.

Current Opinion in Nephrology and Hypertension was launched in 1992. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of nephrology and hypertension is divided into 12 sections that are each reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue. SECTION EDITORS Agnes B FogoAgnes B FogoProfessor Agnes Borge Fogo completed her medical training at Vanderbilt University Medical School, USA. She has remained at Vanderbilt for residency in pathology and fellowship in renal pathology and experimental kidney disease models. Her main research interests are focused on potential regression of chronic kidney disease and tubular-glomerular crosstalk in this process, pursued with funding from the National Institutes of Health and other sources. She is also dedicated to diagnostic renal pathology and has created an online Atlas of Renal Pathology with the American Journal of Kidney Disease and the National Kidney Foundation. She has also authored two books on renal pathology. Prof. Fogo enjoys teaching renal pathology and received the Robert G. Narins award from the American Society of Nephrology in 2011 as well as the Roscoe R. Robinson award from the International Society of Nephrology in 2019, for her contributions in teaching. She is currently President of the ISN and the John L. Shapiro Professor of Pathology, Microbiology and Immunology, Professor of Medicine and Paediatrics and Director of the Renal/Electron Microscopy Laboratory at Vanderbilt University Medical Center, Nashville, Tennessee, USA. Navdeep TangriNavdeep TangriDr Tangri is an attending physician and Professor in the Division of Nephrology, Department of Internal Medicine, and the Rady Faculty of Community Health Sciences at the University of Manitoba, Winnipeg, Canada. Dr Tangri's research program is clinical, translational, and focused on improving clinical decision making for patients with advanced chronic kidney disease. He developed and validated the Kidney Failure Risk Equation to predict the need for dialysis in patients with CKD and is presently engaged in multiple validation and implementation exercises to increase the uptake of the KFRE. In addition, Dr Tangri is conducting a large prospective study on frailty, physical and cognitive function in advanced CKD, as well as leading a multinational randomized trial on the safety and efficacy of a new therapy in this population. He has published over 300 manuscripts, presented at multiple national and international scientific meetings, and is a recipient of the CIHR New Investigator Award and a CIHR Foundation grant.

Optical microsystems for disease diagnosis: an interview with Guillermo Tearney

JOM Associate Editor Dr. Hui Min Leung of Harvard Medical School and Massachusetts General Hospital interviews Dr. Guillermo (Gary) Tearney, the Remondi Family Endowed MGH Research Institute Chair, Professor of Pathology at Harvard Medical School, and an Affiliated Faculty member of the Harvard-MIT Division of Health Sciences and Technology. He maintains a lab at the Wellman Center for Photomedicine at the Massachusetts General Hospital. With the use of advanced endomicroscopy technologies, Tearney’s lab performs development and clinical validation of non-invasive, high-resolution optical imaging methods for human disease diagnosis. Through this interview, he described how he got into the field and how important and relevant optical microsystems are to those research projects. He also gave his thoughts on the future of the field and the grand challenges that remain to be tackled.

Multidisciplinary Integrated Care in Atrial Fibrillation (MICAF): A Systematic Review and Meta-Analysis.

Objective: To assess the effectiveness of multidisciplinary integrated care in the clinical outcomes of atrial fibrillation patients.Methods: Medline, EMBASE, and the CENTRAL trials registry of the Cochrane Collaboration were searched for articles on multidisciplinary integrated care in atrial fibrillation patients. The systematic review and meta-analysis included six and five articles, respectively, that compared the outcomes between the integrated care group and control group.Results: Multidisciplinary integrated care was concomitant with a decrease in all-cause mortality (OR 0.52, 95%CI 0.36-0.74, P=0.0003) and cardiovascular hospitalization (OR 0.66, 95%CI 0.49-0.89, P=0.007). Multidisciplinary integrated care had no significant impact on major adverse cardiovascular event (MACE) (OR 0.76, 95%CI 0.37-1.53, P=0.44), cardiovascular deaths (OR 0.49, 95% CI 0.21-1.17, P=0.11), atrial fibrillation (AF)-related hospitalization (OR 0.76, 95%CI 0.53-1.09, P=0.14), major bleeding (OR 1.02, 95%CI 0.59-1.75, P=0.94), minor bleeding (OR 1.12, 95%CI 0.55-2.26, P=0.76), and cerebrovascular events (OR 0.72, 95%CI 0.45-1.18, P=0.19).Conclusion: In comparison to usual care, a multidisciplinary integrated care approach (i.e., nurse-led care along with usual specialist care) in AF patients is associated with reduced all-cause mortality and cardiovascular hospitalization.

Janus serumbank – jakten på biomarkører for kreft

Janus is a population-based prospective cancer biobank established in 1973. The biobank consists of residual blood serum samples from more than 300 000 men and women, who participated in different health surveys in Norway or as Red Cross blood donors during the period 1972–2004. It was established on the initiative of Professor of Pathology, Olav Torgersen (1907–78), referring to the longstanding maxim that ‘prevention is better than cure’. The purpose of the biobank was to build up a resource for studies of cancer aetiology and early detection of cancer, by measuring biochemical and immunological changes several years before the patient’s diagnosis. The Janus cohort, with comprehensive registry-based follow-up, enables longitudinal assessment of the preclinical stage in cancer patients or the latent period before the tumour has been established, and is ideal for the search of novel biomarkers of cancer. The Cancer Registry of Norway took over the cohort in 2004. In 2019 the biobank was moved into new semi-automated storage facilities and all samples were barcoded. The biobank is annually linked to the Cancer Registry for updates on new cancer cases and by the end of 2020 the number of incident cancer cases in Janus was 107 366. A continuous work in Janus has been on quality assurance of the biospecimens by investigating sample quality parameters like the effect of different pre-processing of the samples as well as storage time and temperature. We have investigated the stability of various hormones, proteins, metabolites, electrolytes and RNAs. This work has contributed to important knowledge in establishing Good Biobank Practice in Norway. In recent years we have also shown that the trace amounts of DNA in Janus is of sufficient quality for genotyping and methylation studies. Today Janus is used in a large number of national and international studies and is an active part in several international cancer consortia. The scientific output from the biobank contains a substantial proportion of high impact papers that have contributed to increased knowledge on cancer biomarkers for use in cancer control. Many of the projects have focused on investigating the association between infections and cancer, environmental exposures and cancer and early detection biomarkers. In recent years we have identified RNAs as early detection and potentially screening biomarkers of cancer. We have developed and optimized an RNA sequencing method for samples with low input RNA and produced RNA profiles of pre-clinical samples from 1631 cancer patients and 673 cancer-free controls. The sequencing data is combined with detailed cancer information from the Cancer Registry of Norway and information on environmental exposures from health surveys, in advanced biocomputational analysis. Results published on the healthy control group shows that RNA expression levels are significantly affected by age and smoking. For lung cancer the results showed dynamic changes in differentially expressed circulating RNAs specific to histology and stage. In the future we aim to utilize Janus in omics analyses and produce large scale datasets that can be shared and used in many research projects.

Erica Ollmann Saphire: How the Study of HIV and Other Viruses Informed the Rapid Development of Vaccines and Therapeutic Antibodies Against COVID-19.

Neil Greenspan, professor of pathology at Case Western Reserve University and senior editor at Pathogens and Immunity talks with Erica Ollmann Saphire, President and Chief Executive Officer of the La Jolla Institute for Immunology, about her work on hemorrhagic fever viruses and SARS-CoV-2. She'll be speaking about these topics at the Keystone Symposium, Lessons from the Pandemic: Responding to Emerging Zoonotic Viral Diseases. Dr. Sapphire is an eminent structural biologist devoted to understanding viral pathogens and pathogenesis.

Editorial introductions.

Current Opinion in Nephrology and Hypertension was launched in 1992. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of nephrology and hypertension is divided into 12 sections that are each reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue. SECTION EDITORS Agnes B. FogoAgnes B. FogoProfessor Agnes B. Fogo completed her medical training at Vanderbilt University Medical School, USA. She has remained at Vanderbilt for residency in pathology and fellowship in renal pathology and experimental kidney disease models. Her main research interests are focused on potential regression of chronic kidney disease and tubular-glomerular crosstalk in this process, pursued with funding from the National Institutes of Health and other sources. She is also dedicated to diagnostic renal pathology and has created an online Atlas of Renal Pathology with the American Journal of Kidney Disease and the National Kidney Foundation. She has also authored two books on renal pathology. Prof. Fogo enjoys teaching renal pathology and received the Robert G. Narins award from the American Society of Nephrology in 2011 as well as the Roscoe R. Robinson award from the International Society of Nephrology in 2019, for her contributions in teaching. She is currently President of the ISN and the John L. Shapiro Professor of Pathology, Microbiology and Immunology, Professor of Medicine and Paediatrics and Director of the Renal/Electron Microscopy Laboratory at Vanderbilt University Medical Center, Nashville, Tennessee, USA. Navdeep TangriNavdeep TangriDr Tangri is an attending physician and Associate Professor in the Division of Nephrology, Department of Medicine and the Department of Community Health Sciences at the University of Manitoba, Canada. Dr Tangri's research program is clinical and translational and focused on improving clinical decision making for patients with advanced chronic kidney disease. He developed and validated the Kidney Failure Risk Equation (KFRE) to predict the need for dialysis in patients with Chronic Kidney Disease (CKD), and is presently engaged in multiple validation and implementation exercises to increase the uptake of the KFRE. In addition, Dr Tangri is conducting a large prospective study on frailty, physical and cognitive function in advanced CKD, as well as leading a multinational randomized trial on the safety and efficacy of a new therapy in this population. He has published over 250 manuscripts and presented at multiple national and international scientific meetings. He is also a recipient of the CIHR New Investigator Award and a CIHR Foundation grant.

German pathology professor Philipp Schwartz: His enduring life from Frankfurt to Istanbul during the Second World War era: A “forgotten savior”

Many scientists were forced to leave Germany mostly under challenging circumstances as a result of the pressure applied to anti-Nazi German scientists and artists (mostly from the medical field) who were or were not of Jewish origin before World War II. They emigrated primarily to the United States, Switzerland, Turkey and South America. Two eminent pathology professors, namely Prof. Philipp Schwartz (from Frankfurt) and Prof. Sigfried Oberndorfer (from Munich) came to Istanbul University. They regarded Turkey as their second homeland. They were obliged to leave Germany due to mounting pressure. Schwartz settled in his father-in-law's house in Zurich. Schwartz was an organizer. He established the “Emergency Society of German Scholars Abroad” (Notgemeinschaft) to gather German scientists and artists in his situation. During the same period, the founder of modern Turkey, Mustafa Kemal Atatürk wanted to apply reforms at Istanbul University to make it attain a Western structure. He invited Swiss pedagogue Prof. Malche and asked him to prepare a report for this purpose. Malche highlighted the need for Western experts is advised. Contact was made with Schwartz's organization in Switzerland. Numerous scientists specialized in almost all fields of science starting with medicine as well as many artists came to Istanbul University and other public institutions. Schwartz established the Pathology Department at Istanbul University while Prof. Oberndorfer established the Department of Experimental Pathology at the same university.Schwartz enabled pathology to gain a contemporary identity in Turkey. Pathology was mostly focused on autopsy during those years. Schwartz attached importance to the pathology training of medical students. He initiated clinico-pathology classes and encouraged surgeons to take a biopsy for surgical pathology. He produced numerous publications. Schwartz worked in Turkey for 19 years and then moved to the US. Thus, a generation of pathologists following the footsteps of Schwartz was raised in Turkey. Frankfurt University, in which he was obliged to leave, erected a stele in his memory at the entrance of the main hospital building. Schwartz thus became an unforgotten savior.

History and continuity of the first therapeutic departments at the Military Medical Academy

The problem of the lack of a statute on the creation of the medicalSurgical Academy arises every time the authors start discussing the history of the medicalSurgical Academy or its subdivisions. There are also misunderstandings in the issue of internal medicine teaching and creation of therapeutic departments. The contents of several historical and archival documents and earlier publications about the period of formation and development of the first therapeutic departments of the Academy (the last third of the 18th to the first half of the 19th century) were clarified. The article also analyzed the general anniversary editions of the academy, dissertations defended on the history of the departments, historical collections, and documents published in the Complete Collection of Laws of the Russian Empire, stored in the archives (Central State Archive of Ancient Acts, Russian State Archive of the Navy, etc.). The teaching of internal medicine started in October 1767 by F.T. Tikhorsky. From 1786, P. Hoffman continued to teach pathology, therapy, and medical practice at the Chief medical School. G.I. Bazilevich was appointed the second professor of pathology and therapy at the MedicoSurgical School. I.A. Smelovsky became the first professor after the college was renamed into academy. I.P. Frank, who created the second therapeutic department, started a direct historical branch of the therapeutic department until 1931, when the Department of the Private Pathology and Therapy merged with the united therapeutic department, and the Department of Propaedeutics of Internal Diseases emerged from it. From 1848 to 1924, the Department of General Therapy, attached to the first department, existed. In 1806, thanks to I.P. Frank, the second therapeutic department was founded, which existed since 1810 and is now the Department of General Therapy. Initially created as the Department of Hospital Therapy Clinic and renamed in 1965 at the insistence of N.S. Molchanov into the Department of Therapeutic Advancement of Physicians № 1 was actually created by the Decree of January 19th, 1842, simultaneously with the appointment of its first full-time head Prof. O.I. Myanovsky.

Asymptomatic bilateral facial swelling

A 54-year-old Black woman sought treatment at the oral medicine clinic at the School of Dental Medicine at the University of Pennsylvania for evaluation of bilateral facial swelling. The patient endorsed that the swelling had been present for the past 18 months but denied any associated symptoms, including pain, drainage, facial weakness, facial numbness, or any history of facial swelling. The patient denied constitutional symptoms, including fatigue, fever, chills, or unintentional weight loss. She denied history of trauma to the face and endorsed that the swelling had increased slowly over time. The patient denied alleviating or exacerbating factors. She reported that the amount of swelling did not change with oral nutritional intake. The patient denied a history of head and neck cancer and head and neck radiation therapy. Her medical history included hypertension, anxiety, and insomnia. Medications included metoprolol, nifedipine, and olmesartan. Social history included smoking 6 to 7 cigarettes per day for the past 15 years and consuming 1 to 2 alcoholic drinks per month without any history of alcohol abuse or recreational drug use. The review of systems was negative after detailed evaluation. Dr. Almasri was a resident, Department of Oral Medicine, University of Pennsylvania School of Dental Medicine, Philadelphia, PA, when the work described in this article was conducted. Dr. Gustafson is an associate professor of pathology and laboratory medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. Dr. Husson is a professor of clinical pathology and laboratory medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. Dr. Shanti is an assistant professor of oral and maxillofacial surgery, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA and an assistant professor of otorhinolaryngology/head and neck surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. Dr. France is an assistant professor of oral medicine, Department of Oral Medicine, School of Dental Medicine, University of Pennsylvania, 240 S 40th St, Philadelphia, PA 19104

Keys to the successful preclinical-clinical translation of next-gen CAR-T cell therapy

Devon J Shedlock, PhD, is Chief Scientific Officer, Cell Therapies at Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure. He joined Poseida as its first employee in 2015 and most recently served as Senior Vice President of Research and Development. Dr Shedlock is a key scientific contributor in the application of the Company’s proprietary gene engineering platform technologies to develop novel cell therapy programs. Before joining Poseida, he held positions as an adjunct assistant professor of pathology and laboratory medicine at the Perelman School of Medicine and associate director of the T-Cell Engineering Laboratory that is part of Carl June’s group, both at the University of Pennsylvania. Dr Shedlock received his PhD in cell and molecular biology from the University of Pennsylvania, and a BS with Honors in biology from Ursinus College in Collegeville, Pennsylvania.

Dr. P. V. Gharpure - An eminent Indian pathologist and a pioneer in starting oral polio vaccination in India.

Dr. Purushottam Vishwanath Gharpure was an eminent Indian pathologist and an emeritus Professor of Pathology at the Grant Medical College, Bombay. He was a pioneer in carrying out the first field trial of polio vaccination which marked the beginning of the polio eradication program in India. Dr. Gharpure set an example by taking his laboratory work to the field and proving how the laboratory research can be used to better the society. The mesmerizing story of Dr. "Gharpure's life" is described in this paper.

Diversity, equity, and inclusion in pathology: Some progress, but room for improvement: Amid a troubling backslide in diversifying medicine, pathologists point to recent successes and remaining challenges in promoting diversity, equity, and inclusion (DEI). In part 1 of a 2-part series, we investigate what has and has not worked in efforts to diversify workforces.

Diversity, equity, and inclusion in pathology: Some progress, but room for improvement: Amid a troubling backslide in diversifying medicine, pathologists point to recent successes and remaining challenges in promoting diversity, equity, and inclusion (DEI). In part 1 of a 2-part series, we investigate what has and has not worked in efforts to diversify workforces.

Prostate cancer nomenclature at diagnosis can affect treatment decisions.

Prostate cancer nomenclature at diagnosis can affect treatment decisions.

Mobilizing Traditions in the First Wave of the British Animal Defense Movement

Book Review| October 01 2021 Mobilizing Traditions in the First Wave of the British Animal Defense Movement Mobilizing Traditions in the First Wave of the British Animal Defense Movement. By Chien-hui Li. (Basingstoke, England: Palgrave Macmillan, 2019. Palgrave Macmillan Animal Ethics Series. 355 + xvii pp. Hardback. €114.39. ISBN: 978-1-137-52650-2.). A. W. H. Bates A. W. H. Bates A. W. H. BATES is medical director of Convit House Pathology Ltd., honorary associate professor of pathology at University College London, and emeritus consultant pathologist at the Royal Free Hospital. Email: ConvitHouse@protonmail.com Search for other works by this author on: This Site Google Journal of Animal Ethics (2021) 11 (2): 110–111. https://doi.org/10.5406/janimalethics.11.2.0110 Cite Icon Cite Share Icon Share Facebook Twitter LinkedIn MailTo Permissions Search Site Citation A. W. H. Bates; Mobilizing Traditions in the First Wave of the British Animal Defense Movement. Journal of Animal Ethics 1 January 2021; 11 (2): 110–111. doi: https://doi.org/10.5406/janimalethics.11.2.0110 Download citation file: Zotero Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All Scholarly Publishing CollectiveUniversity of Illinois PressJournal of Animal Ethics Search Advanced Search The text of this article is only available as a PDF. Copyright 2021 by the Board of Trustees of the University of Illinois2021 Article PDF first page preview Close Modal You do not currently have access to this content.